Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.34 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.34 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3892676 | 1.00 | TAS2R14 (0.39) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL6159533 | 0.90 | TAS2R14 (0.39) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL28336662 | 0.86 | HCRTR1 (0.37) | MRGPRX4OPRL1HIF1AP2RX7HCRTR1 | |
| SCHEMBL4648199 | 0.81 | TAS2R14 (0.39) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL31634978 | 0.81 | TAS2R14 (0.40) | TAS2R14MRGPRX4P2RX7HCRTR1HCRTR2 | |
| SCHEMBL20552906 | 0.81 | TAS2R14 (0.40) | TAS2R14MRGPRX4P2RX7HCRTR1HCRTR2 | |
| SCHEMBL30748265 | 0.81 | TAS2R14 (0.37) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL1132765 | 0.81 | TAS2R14 (0.37) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL1132769 | 0.81 | TAS2R14 (0.37) | TAS2R14MRGPRX4OPRL1HIF1ASYK | |
| SCHEMBL4089901 | 0.81 | PTGS1 (0.36) | MRGPRX4OPRL1HIF1ASYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050085389-A1 | Seed treatment compositions | SYNGENTA CROP PROTECTION, INC. | 2005-04-21 | — | — | US | claimed |
| EP-1267617-B1 | FUNGICIDAL METHOD | HERCULES INC (US) | 2005-02-09 | — | — | EP | claimed |
| US-10206391-B2 | Strobilurin formulations | VIVE CROP PROTECTION INC. (CA) | 2019-02-19 | — | — | US | disclosed |
| US-20140364310-A1 | STROBILURIN FORMULATIONS | VIVE CROP PROTECTION INC. (CA) | 2014-12-11 | — | — | US | disclosed |
| US-8008230-B2 | Synergistic antifungal DDAC compositions | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-08-30 | — | — | US | disclosed |
| JP-2010168393-A | SYNERGISTIC SEED TREATMENT COMPOSITION | SYNGENTA PARTICIPATIONS AG | 2010-08-05 | — | — | JP | disclosed |
| US-20070293395-A1 | Use of 2-Substituted Pyrimidines for Combating Nematode Diseases of Plants | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | disclosed |
| CN-1332604-C | Synergistic Seed Treatment Composition | SYNGENTA PARTICIPATIONS AG (CH) | 2007-08-22 | — | — | CN | disclosed |
| US-20070142410-A1 | Synergistic antifungal ddac compositions | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-06-21 | — | — | US | disclosed |
| EP-1793676-A1 | USE OF 2-SUBSTITUTED PYRIMIDINES FOR COMBATING NEMATODE OF PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006032526-A1 | USE OF 2-SUBSTITUTED PYRIMIDINES FOR COMBATING NEMATODE OF PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | WO | disclosed |
| US-20050085389-A1 | Seed treatment compositions | SYNGENTA CROP PROTECTION, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050085389-A1 | Seed treatment compositions | SYNGENTA CROP PROTECTION, INC. | 2005-04-21 | — | — | US | disclosed |
| CN-1604738-A | Synergistic Seed Treatment Composition | SYNGENTA PARTICIPATIONS AG (CH) | 2005-04-06 | — | — | CN | disclosed |
| US-20050065031-A1 | Synergistic seed treatment compositions | LANXESS CORPORATION | 2005-03-24 | — | — | US | disclosed |
| WO-2004082383-A1 | USE OF TRIAZOLOPYRIMIDINES FOR COMBATING NEMATODE DISEASES OF PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-30 | — | — | WO | disclosed |
| EP-1450606-A1 | SYNERGISTIC SEED TREATMENT COMPOSITIONS | Syngenta Participations AG (CH) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003045147-A1 | SYNERGISTIC SEED TREATMENT COMPOSITIONS | SYNGENTA PARTICIPATIONS AG (CH) | 2003-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364310-A1 | STROBILURIN FORMULATIONS | CD63, SNU13, SNX1 | TAS2R14 4451/4885MRGPRX4 3478/4885OPRL1 4869/4885 |
| US-10206391-B2 | Strobilurin formulations | CD63, SNU13, SNX1 | TAS2R14 4451/4885MRGPRX4 3478/4885OPRL1 4869/4885 |
| US-20070293395-A1 | Use of 2-Substituted Pyrimidines for Combating Nematode Diseases of Plants | TYMS, UMPS, NUDT1 | TAS2R14 3049/4885MRGPRX4 798/4885OPRL1 2863/4885 |
| US-20070142410-A1 | Synergistic antifungal ddac compositions | AADAC, BRD3, DDC | TAS2R14 471/4885MRGPRX4 3820/4885OPRL1 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.